Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/35970
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorSerna Ortega, Paula Andrea-
dc.contributor.authorAguilar Jiménez, Wbeimar-
dc.contributor.authorFlorez Álvarez, Lizdany-
dc.contributor.authorTrabattoni, Daria-
dc.contributor.authorRúgeles López, María Teresa-
dc.contributor.authorBiasin, Mara-
dc.date.accessioned2023-07-19T19:43:20Z-
dc.date.available2023-07-19T19:43:20Z-
dc.date.issued2020-
dc.identifier.citationSerna-Ortega PA, Aguilar-Jimenez W, Florez-Álvarez L, Trabattoni D, Rugeles MT, Biasin M. IL-21 is associated with natural resistance to HIV-1 infection in a Colombian HIV exposed seronegative cohort. Microbes Infect. 2020 Sep;22(8):371-374. doi: 10.1016/j.micinf.2019.11.002. Epub 2019 Dec 7. PMID: 31816393.spa
dc.identifier.issn1286-4579-
dc.identifier.urihttps://hdl.handle.net/10495/35970-
dc.description.abstractABSTRACT: Higher IL-21 levels were associated with natural resistance to HIV infection in an Italian cohort. Thus we wanted to confirm such association in HIV exposed seronegative individuals (HESN) from Colombia. Cells from HESN were less susceptible to infection and expressed higher IL-21 mRNA levels than healthy controls at both baseline and 7-days post-infection; similar results were observed for IL-6, perforin, and granzyme. These results suggest that IL-21/IL-6 increase may be a distinctive quality in the profile of HIV 1 resistance, at least during sexual exposure. However, further studies are necessary to confirm the specific protective mechanisms of these cytokines.spa
dc.format.extent3spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherElsevierspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleIL-21 is associated with natural resistance to HIV-1 infection in a Colombian HIV exposed seronegative cohortspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupInmunovirologíaspa
dc.identifier.doi10.1016/j.micinf.2019.11.002-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1769-714X-
oaire.citationtitleMicrobes and infectionspa
oaire.citationstartpage371spa
oaire.citationendpage374spa
oaire.citationvolume22spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.publisher.placeEstados Unidosspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTCORTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsReceptores de Interleucina-21-
dc.subject.decsReceptors, Interleukin-21-
dc.subject.decsSíndrome de Inmunodeficiencia Adquirida-
dc.subject.decsAcquired Immunodeficiency Syndrome-
dc.subject.decsCitocinas-
dc.subject.decsCytokines-
dc.subject.decsEnfermedades del Sistema Inmune-
dc.subject.decsImmune System Diseases-
dc.description.researchgroupidCOL0012444spa
dc.relation.ispartofjournalabbrevMicrobes Infect.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
AguilarWbeimar_2019_IL21AssociatedNaturalResistanceHIV1.pdfArtículo de investigación591.01 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons